Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012.
Dinmohamed AG, Visser O, van Norden Y, Blijlevens NM, Cornelissen JJ, Huls GA, Huijgens PC, Sonneveld P, van de Loosdrecht AA, Ossenkoppele GJ, Löwenberg B, Jongen-Lavrencic M. Dinmohamed AG, et al. Among authors: huijgens pc. Leukemia. 2016 Jan;30(1):24-31. doi: 10.1038/leu.2015.188. Epub 2015 Jul 17. Leukemia. 2016. PMID: 26183645
High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome.
Feller N, Schuurhuis GJ, van der Pol MA, Westra G, Weijers GW, van Stijn A, Huijgens PC, Ossenkoppele GJ. Feller N, et al. Among authors: huijgens pc. Leukemia. 2003 Jan;17(1):68-75. doi: 10.1038/sj.leu.2402781. Leukemia. 2003. PMID: 12529662 Clinical Trial.
Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry.
Dinmohamed AG, van Norden Y, Visser O, Posthuma EF, Huijgens PC, Sonneveld P, van de Loosdrecht AA, Jongen-Lavrencic M. Dinmohamed AG, et al. Among authors: huijgens pc. Leukemia. 2015 Dec;29(12):2449-51. doi: 10.1038/leu.2015.220. Epub 2015 Sep 15. Leukemia. 2015. PMID: 26369829 No abstract available.
Quantitative enzyme determination in acute myeloid leukemia.
Ossenkoppele GJ, Wijermans PJ, Huijgens PC, Nauta JJ, Langenhuijsen MM. Ossenkoppele GJ, et al. Among authors: huijgens pc. Leuk Res. 1991;15(6):481-6. doi: 10.1016/0145-2126(91)90059-3. Leuk Res. 1991. PMID: 1650411
Radiotoxicity of 67-gallium on myeloid leukemic blasts.
Jonkhoff AR, Huijgens PC, Versteegh RT, van Lingen A, Ossenkoppele GJ, Dräger AM, Teule GJ. Jonkhoff AR, et al. Among authors: huijgens pc. Leuk Res. 1995 Mar;19(3):169-74. doi: 10.1016/0145-2126(94)00130-3. Leuk Res. 1995. PMID: 7700078
Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with amsidine. Dutch Hematology-Oncology Working Group for Adults (HOVON).
Daenen S, Löwenberg B, Sonneveld P, van Putten WL, Verhoef G, Verdonck LF, van Veldhoven M, Huijgens PC. Daenen S, et al. Among authors: huijgens pc. Leukemia. 1994 Jan;8(1):6-10. Leukemia. 1994. PMID: 8289499 Clinical Trial.
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.
Löwenberg B, Boogaerts MA, Daenen SM, Verhoef GE, Hagenbeek A, Vellenga E, Ossenkoppele GJ, Huijgens PC, Verdonck LF, van der Lelie J, Wielenga JJ, Schouten HC, Gmür J, Gratwohl A, Hess U, Fey MF, van Putten WL. Löwenberg B, et al. Among authors: huijgens pc. J Clin Oncol. 1997 Dec;15(12):3496-506. doi: 10.1200/JCO.1997.15.12.3496. J Clin Oncol. 1997. PMID: 9396403 Clinical Trial.
262 results